Literature DB >> 15843536

Priming in the presence of IL-10 results in direct enhancement of CD8+ T cell primary responses and inhibition of secondary responses.

Silvia S Kang1, Paul M Allen.   

Abstract

Although IL-10 acts as an inhibitory cytokine for APC and CD4(+) T cell function, its effects on CD8(+) T cells are unclear. Additionally, little is known about whether initial priming in the presence of IL-10 can have long-lasting effects and influence subsequent CD8(+) T cell responses that occur in the absence of the cytokine. In the present study, we clarified the role of IL-10 during primary responses and examined whether exposure to IL-10 during initial priming of CD8(+) T cells impacted secondary responses. To determine the effect of IL-10 on Ag-specific T cell responses, peptide-pulsed IL-10R2(-/-) splenic dendritic cells were used to prime T cells from OT-I CD8(+) TCR transgenic mice. During the primary response, the presence of IL-10 resulted in enhancement of CD8(+) T cell numbers without detectable alterations in the kinetics or percentage of cells that underwent proliferation. A modest increase in survival, not attributable to Bcl-2 or Bcl-x(L), was also observed with IL-10 treatment. Other parameters of CD8(+) T cell function, including IL-2, IFN-gamma, TNF-alpha, and granzyme production, were unaltered. In contrast, initial exposure to IL-10 during the primary response resulted in decreased OT-I expansion during secondary stimulation. This was accompanied by lowered IL-2 levels and reduced percentages of proliferating BrdU(+) cells and OT-I cells that were CD25(high). IFN-gamma, TNF-alpha, and granzyme production were unaltered. These data suggest that initial exposure of CD8(+) T cells to IL-10 may be temporarily stimulatory; however, programming of the cells may be altered, resulting in diminished overall responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843536     DOI: 10.4049/jimmunol.174.9.5382

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Programming CD8+ T cells for effective immunotherapy.

Authors:  Christian S Hinrichs; Luca Gattinoni; Nicholas P Restifo
Journal:  Curr Opin Immunol       Date:  2006-04-17       Impact factor: 7.486

2.  IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection.

Authors:  David G Brooks; Kevin B Walsh; Heidi Elsaesser; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

3.  IL-10 Regulates Memory T Cell Development and the Balance between Th1 and Follicular Th Cell Responses during an Acute Viral Infection.

Authors:  Yuan Tian; Sarah B Mollo; Laurie E Harrington; Allan J Zajac
Journal:  J Immunol       Date:  2016-07-08       Impact factor: 5.422

Review 4.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

Review 5.  Current status of interleukin-10 and regulatory T-cells in cancer.

Authors:  Kristen L Dennis; Nichole R Blatner; Fotini Gounari; Khashayarsha Khazaie
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

6.  Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.

Authors:  Mark J Dobrzanski; Kathleen A Rewers-Felkins; Khaliquzzaman A Samad; Imelda S Quinlin; Catherine A Phillips; William Robinson; David J Dobrzanski; Stephen E Wright
Journal:  Cancer Immunol Immunother       Date:  2011-11-15       Impact factor: 6.968

7.  IL-21 mediates suppressive effects via its induction of IL-10.

Authors:  Rosanne Spolski; Hyoung-Pyo Kim; Wei Zhu; David E Levy; Warren J Leonard
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Authors:  Lyse A Norian; Paulo C Rodriguez; Leigh A O'Mara; Jovanny Zabaleta; Augusto C Ochoa; Marina Cella; Paul M Allen
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

9.  IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17.

Authors:  Curtis J Henry; David A Ornelles; Latoya M Mitchell; Kristina L Brzoza-Lewis; Elizabeth M Hiltbold
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

10.  Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic Hepatitis.

Authors:  M Özgüler; H H Akbulut; A Akbulut
Journal:  West Indian Med J       Date:  2015-01-27       Impact factor: 0.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.